about
A prospective study of plasma C-peptide and colorectal cancer risk in menA Practical Review of C-Peptide Testing in DiabetesChanges in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000.Onset features and subsequent clinical evolution of childhood diabetes over several years.Glucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications.The prognosis of diabetic retinopathy in patients with type 2 diabetes since 1996-1998: the Skaraborg Diabetes Register.Biomarkers related to severe hypoglycaemia and lack of good glycaemic control in ACCORDEffects of Vitamin D Supplementation on C-peptide and 25-hydroxyvitamin D Concentrations at 3 and 6 Months.Duration of Diabetes Predicts Aortic Pulse Wave Velocity and Vascular Events in Alström Syndrome.HLA-DQ haplotypes differ by ethnicity in patients with childhood-onset diabetes.Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis.Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetesCharacteristics of maturity onset diabetes of the young in a large diabetes center.The clinical utility of C-peptide measurement in the care of patients with diabetesComparison of consumption behavior and appetite sensations among patients with type 2 diabetes mellitus after bariatric surgery.Biomarkers associated with severe hypoglycaemia and death in ACCORD.Development and validation of empirical indices to assess the insulinaemic potential of diet and lifestyle.Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic.[C-peptide residual secretion makes difference on type 1 diabetes management?].Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia.Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes.Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes?C-peptide levels and the risk of diabetes and pre-diabetes among Chinese women with gestational diabetes.Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes.Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.High plasma levels of CD40 are associated with low coenzyme Q and vitamin E content of low‐density lipoprotein in healthy men
P2860
Q28168133-60AD2AC6-1D31-4FAF-9708-BAC44B7F78A0Q33732640-EB7D235D-B5CE-4D71-967C-B9F033C2435DQ34629000-D70CE791-09AE-435F-9C74-F1F552BEB4F3Q35011855-A6CEB101-4DC4-43C8-BF3E-D28566A66966Q35087846-D6273A73-D5C5-4BF2-8B60-A833761AFFD6Q35229103-1C30C8F2-820C-4FE7-B46A-EC2EC521E469Q35561497-63C8D7D4-BF64-4534-B5EB-BCFA367A5481Q35764892-E6BED252-9960-4BFB-BAF2-B8918DC915C9Q35916546-814AC640-2286-4611-A853-178E08A86D65Q36121842-096AA164-F1F1-4BEF-A7AE-7C1935613F89Q36818151-8342CED1-D734-42A2-A971-14E31373F870Q36906207-8F845F2B-7F24-4A45-A135-3F6A3FD4D540Q37068285-C672C8D8-5655-4DA5-820C-4EF033BD29C2Q37108880-6D3695A0-DFF1-4FDA-91EA-B49FB2BC3C52Q37717858-3B50DA2A-60A0-4B24-8060-54C1228FB980Q38371823-CB549241-172E-416D-80C5-44E061443A17Q39208004-9C47C18A-6424-4A29-8226-CF8E28C13AAAQ41251582-A1BC90ED-9AC7-434C-8741-AAE27CA1FA17Q46625419-A6773BBA-35DC-40BB-92D4-859B9CADBC8BQ47567739-A4F2DC3C-F296-4169-9BAD-7B29A8703AECQ47579527-0A6183A4-C041-4392-858E-8CCBE641F931Q49885981-3F8CD7C8-8AD7-46C5-91F2-88CB0A213E09Q50053135-272D138C-5B45-45A8-ABC3-4F9E85F8E3A0Q51280338-5C5EF608-DA96-4563-BAD6-DC41702EF418Q52874770-05C61ACE-52B0-4461-9BE1-631AFC897B5CQ57623034-C945346B-CD0C-4641-AE2E-CB54BA996BDB
P2860
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Random C-peptide in the classification of diabetes.
@en
Random C-peptide in the classification of diabetes.
@nl
type
label
Random C-peptide in the classification of diabetes.
@en
Random C-peptide in the classification of diabetes.
@nl
prefLabel
Random C-peptide in the classification of diabetes.
@en
Random C-peptide in the classification of diabetes.
@nl
P2093
P2860
P1476
Random C-peptide in the classification of diabetes.
@en
P2093
Stenström G
Sundkvist G
P2860
P304
P356
10.1080/00365510050216411
P577
2000-12-01T00:00:00Z